➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Harvard Business School
Boehringer Ingelheim
Baxter
Dow

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

CLOBETASOL PROPIONATE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Clobetasol Propionate patents expire, and when can generic versions of Clobetasol Propionate launch?

Clobetasol Propionate is a drug marketed by Glenmark Pharms Ltd, Ingenus Pharms Llc, Perrigo Israel, Perrigo Uk Finco, Taro, Aleor Dermaceuticals, Amneal Pharms Llc, Cosette, Fougera Pharms Inc, Glenmark Pharms, Lupin Ltd, Mylan, Rising, Teligent Pharma Inc, Teva Pharms Usa, Torrent, Xiromed, Zydus Pharms, Fougera Pharms, Perrigo Co, Actavis Mid Atlantic, Cadila, Hi Tech, Encube, Novel Labs Inc, Macleods Pharms Ltd, Saptalis Pharms, Tolmar, Wockhardt Bio Ag, Akorn, Apotex, and Paddock Llc. and is included in seventy-one NDAs.

The generic ingredient in CLOBETASOL PROPIONATE is clobetasol propionate. There are fourteen drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

US ANDA Litigation and Generic Entry Outlook for Clobetasol Propionate

A generic version of CLOBETASOL PROPIONATE was approved as clobetasol propionate by COSETTE on February 16th, 1994.

  Start Trial

Drug patent expirations by year for CLOBETASOL PROPIONATE
Drug Prices for CLOBETASOL PROPIONATE

See drug prices for CLOBETASOL PROPIONATE

Drug Sales Revenue Trends for CLOBETASOL PROPIONATE

See drug sales revenues for CLOBETASOL PROPIONATE

Recent Clinical Trials for CLOBETASOL PROPIONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Malmö UniversityPhase 2/Phase 3
Skane University HospitalPhase 2/Phase 3
SalvatPhase 3

See all CLOBETASOL PROPIONATE clinical trials

Pharmacology for CLOBETASOL PROPIONATE
Medical Subject Heading (MeSH) Categories for CLOBETASOL PROPIONATE
Paragraph IV (Patent) Challenges for CLOBETASOL PROPIONATE
Tradename Dosage Ingredient NDA Submissiondate
IMPOYZ CREAM;TOPICAL clobetasol propionate 209483 2019-12-06
OLUX E AEROSOL, FOAM;TOPICAL clobetasol propionate 022013 2010-02-25
CLOBEX SPRAY;TOPICAL clobetasol propionate 021835 2008-09-29
CLOBEX SHAMPOO;TOPICAL clobetasol propionate 021644 2008-01-09
CLOBEX LOTION;TOPICAL clobetasol propionate 021535 2006-03-27
OLUX AEROSOL, FOAM;TOPICAL clobetasol propionate 021142 2005-06-27

US Patents and Regulatory Information for CLOBETASOL PROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teligent Pharma Inc CLOBETASOL PROPIONATE clobetasol propionate OINTMENT;TOPICAL 208589-001 Jan 23, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Aleor Dermaceuticals CLOBETASOL PROPIONATE clobetasol propionate OINTMENT;TOPICAL 211800-001 Mar 4, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Aleor Dermaceuticals CLOBETASOL PROPIONATE clobetasol propionate SOLUTION;TOPICAL 212881-001 Oct 21, 2019 AT RX No No   Start Trial   Start Trial   Start Trial
Akorn CLOBETASOL PROPIONATE clobetasol propionate SPRAY;TOPICAL 207218-001 Apr 28, 2017 AT RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Harvard Business School
Boehringer Ingelheim
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.